Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran
Mirsaeidi SM, Tabarsi P, Khoshnood K, Pooramiri MV, Rowhani-Rahbar A, Mansoori SD, Masjedi H, Zahirifard S, Mohammadi F, Farnia P, Masjedi MR, Velayati AA. Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran. International Journal Of Infectious Diseases 2005, 9: 317-322. PMID: 16183321, DOI: 10.1016/j.ijid.2004.09.012.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAmikacinAntitubercular AgentsCycloserineDrug Therapy, CombinationFemaleHumansIranIsoniazidMaleMiddle AgedOfloxacinTreatment OutcomeTuberculosis, Multidrug-ResistantConceptsMultiple drug-resistant tuberculosisMore second-line drugsDrug-resistant tuberculosis treatmentMDR-TB patientsMDR-TB treatmentMasih Daneshvari HospitalDrug-resistant tuberculosisSecond-line drugsAppropriate treatment regimensProbable cureDrug regimenTreatment regimenComplete followTreatment regimensTuberculosis treatmentPatientsAverage durationRegimenTreatmentDrugsCureRegimensAmikacinHospitalFollowBarriers to completion of tuberculosis treatment among prisoners and former prisoners in St. Petersburg, Russia.
Fry RS, Khoshnood K, Vdovichenko E, Granskaya J, Sazhin V, Shpakovskaya L, Zhemkov V, Zhemkova M, Rowhani-Rahbar A, Funk M, Kozlov A. Barriers to completion of tuberculosis treatment among prisoners and former prisoners in St. Petersburg, Russia. The International Journal Of Tuberculosis And Lung Disease 2005, 9: 1027-33. PMID: 16158896.Peer-Reviewed Original ResearchMeSH KeywordsAdultComorbidityFemaleHumansMalePrisonersRisk FactorsRussiaSocial WelfareTuberculosisTuberculosis, Multidrug-ResistantUrban Population